SFRP2 and myocardial infarction: Additionally, wnt3a has been published in previous studies of myocardial infarction-induced apoptosis, where increased levels of wnt3a were observed after the infarct was generated, whereas sFRP2 administration attenuated this wnt3a activity [15].